Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study (vol 45, pg 666, 2022)
单位:[1]Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Endocrinol Ctr, Beijing, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China[3]Da Qing First Hosp, Dept Cardiol, Da Qing, Peoples R China[4]Chinese Acad Med Sci & Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Med Res & Biometr Ctr, Beijing, Peoples R China[5]China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
第一作者单位:[1]Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Endocrinol Ctr, Beijing, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Chen Yanyan,Jia Hongmei,Qian Xin,et al.Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study (vol 45, pg 666, 2022)[J].DIABETES CARE.2022,45(7):1699-1699.doi:10.2337/dc22-er07a.
APA:
Chen, Yanyan,Jia, Hongmei,Qian, Xin,Wang, Jinping,Yu, Meng...&Li, Guangwei.(2022).Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study (vol 45, pg 666, 2022).DIABETES CARE,45,(7)
MLA:
Chen, Yanyan,et al."Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study (vol 45, pg 666, 2022)".DIABETES CARE 45..7(2022):1699-1699